Centene (CNC) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.58
- Estimate
- $0.10
- Surprise
- +496.6%
- Revenue (period 2026-09-30)
- $45.10B
- Score today
- 5.2/10
Revenue source: xbrl.
How the report landed
Centene (CNC) beat the $0.10 estimate with adjusted EPS of $0.58 — a large 496.6% upside surprise.
Coverage in the report window
- Coca-Cola To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Wednesday — benzinga, 2026-10-28
- Centene Analysts Boost Their Forecasts Following Upbeat Q3 Earnings — benzinga, 2026-10-28
- Baird Maintains Neutral on Centene, Raises Price Target to $71 — benzinga, 2026-10-28
Where TrendMatrix's rating stands now
TrendMatrix currently rates CNC Sell at 5.2/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +496.6% surprise compares with a +172.4% four-quarter average.
What argues against it
- Concentration risk — Product: Medicaid segment (57.0%)
- Target reached (-4.3% upside)
- Quality below floor (2.3 < 4.0)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $68.71
- Stop
- $63.90
The stock trades at 23.6× trailing but 12.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 2.5× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-10-28 — shown for context, not personalized investment advice.
CNC at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Healthcare Plans
- Market cap
- $33.94B
- P/E (fwd)
- 12.8
- P/E (ttm)
- 23.6
- 52-week range
- $31.63–$72.50
- Off 52-week high
- 5.2%
- RSI (14)
- 62
- Volume vs avg
- 2.55×
- Score today
- 5.2/10